about
Maternal methadone dose, placental methadone concentrations, and neonatal outcomes.Bioanalysis for cocaine, opiates, methadone, and amphetamines exposure detection during pregnancy.Hydrophilic interaction liquid chromatography-tandem mass spectrometry (HILIC-MS/MS) determination of cocaine and its metabolites benzoylecgonine, ecgonine methyl ester, and cocaethylene in hair samples.Quantification of selected synthetic cannabinoids and Δ9-tetrahydrocannabinol in oral fluid by liquid chromatography-tandem mass spectrometry.Maternal hair analysis for the detection of illicit drugs, medicines, and alcohol exposure during pregnancy.Development and validation of a method for the quantitation of Delta9tetrahydrocannabinol in oral fluid by liquid chromatography electrospray-mass-spectrometry.A sensitive, rapid and specific determination of midazolam in human plasma and saliva by liquid chromatography/electrospray mass spectrometry.LC-MS/MS method for the determination of nine antidepressants and some of their main metabolites in oral fluid and plasma. Study of correlation between venlafaxine concentrations in both matrices.Determination of MDMA, MDA, MDEA and MBDB in oral fluid using high performance liquid chromatography with native fluorescence detection.Determination of illicit and medicinal drugs and their metabolites in oral fluid and preserved oral fluid by liquid chromatography-tandem mass spectrometry.Determination of drugs of abuse and their metabolites in human plasma by liquid chromatography-mass spectrometry. An application to 156 road fatalities.Detection of in utero cannabis exposure by umbilical cord analysis.Simultaneous determination of opiates, methadone, amphetamines, cocaine, and metabolites in human placenta and umbilical cord by LC-MS/MS.Confirmation by LC-MS of drugs in oral fluid obtained from roadside testing.Usefulness of hair analysis and psychological tests for identification of alcohol and drugs of abuse consumption in driving license regranting.High-throughput on-line solid-phase extraction-liquid chromatography-tandem mass spectrometry method for the simultaneous analysis of 14 antidepressants and their metabolites in plasma.Combined drug screening and confirmation by liquid chromatography time-of-flight mass spectrometry with reverse database searchFast LC-MS/MS method for the determination of amphetamine, methamphetamine, MDA, MDMA, MDEA, MBDB and PMA in urineTarget screening and confirmation of 35 licit and illicit drugs and metabolites in hair by LC-MSMSMolecularly imprinted polymer for selective determination of Δ9-tetrahydrocannabinol and 11-nor-Δ9-tetrahydrocannabinol carboxylic acid using LC-MS/MS in urine and oral fluidAssessment of different mouthwashes on cannabis oral fluid concentrationsDevelopment and validation of a liquid chromatography-tandem mass spectrometry method for the determination of nicotine and its metabolites in placenta and umbilical cordA multidrug LC-MS/MS method for the determination of five immunosuppressants in oral fluidAssessment of Tobacco Exposure During Pregnancy by Meconium Analysis and Maternal InterviewA LC-MS/MS method for the determination of common synthetic cathinones in meconiumLiquid chromatography tandem mass spectrometry determination of selected synthetic cathinones and two piperazines in oral fluid. Cross reactivity study with an on-site immunoassay device
P50
Q34626408-9C7A772A-6065-4A6F-863C-A78B41DEADAAQ39422252-23A87B07-C957-4BFF-88BC-D9C7BB410D0CQ43201579-1D9EF0BC-B86E-4888-A1D6-1C64AC1E90C7Q43903051-54F3CB77-A792-414D-944E-D9421471EA2DQ44425101-AFC899E6-B33D-4FED-90A2-5CE6862ACE66Q45068670-120731CA-7B67-471F-993B-BCB2A4B35C05Q45146193-9BCC61BA-7F10-4BB5-BE2D-427AE31A9E6CQ46500759-F0F6DEEF-7F33-4F24-B758-22D04ADD3936Q46535191-40145A01-A90B-4B49-8DA7-5C5DB6BE3EBAQ46592842-0CF6C249-5591-4966-91E0-69560E91BB16Q46911337-3E22D270-F935-4DA2-9C7E-1F78F3FC7173Q47921404-7C669AFB-EFAD-4984-AA80-2DC22882FDABQ48091451-70D6AB86-2950-41C2-A1D7-377847CCA2B2Q48579876-FB9B2F65-A4E6-460E-9018-E310AF36E4F5Q51732091-DEEEAECE-7065-424C-85CB-6121DFF78598Q53018191-FB1A3D35-10FD-4ECA-AD48-5351BD2673D4Q61037222-EA557B08-2399-435B-8B5F-60F8C8375F2BQ79347578-9DA574BF-D760-4109-BED7-D36740C28A63Q82767617-1CF033DA-BA62-4EF9-B86F-98B3F2AAF4AAQ87106615-E0E00A99-AC43-428D-BA89-CD3B63673EACQ87147644-589A2CC3-CF07-4421-AD11-CFF83B983046Q88014084-5FC049D9-6F49-4C85-8523-C851592983A0Q90057419-96F7C088-A295-47AB-A636-6C6B1515793DQ90750250-EBB5CB5F-8C9D-4F7B-A6C3-6CFFBE4A6D2DQ91677956-AD11E439-3A37-476E-AEAB-AA6A74888DAFQ95614243-7DD5820A-D97C-4C23-BBA5-FB4F72A6F235
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ana de Castro
@ast
Ana de Castro
@en
Ana de Castro
@es
Ana de Castro
@nl
Ana de Castro
@sl
type
label
Ana de Castro
@ast
Ana de Castro
@en
Ana de Castro
@es
Ana de Castro
@nl
Ana de Castro
@sl
prefLabel
Ana de Castro
@ast
Ana de Castro
@en
Ana de Castro
@es
Ana de Castro
@nl
Ana de Castro
@sl
P1053
M-5159-2015
P106
P21
P31
P3829
P496
0000-0002-9832-012X